Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Feb;84(3):423–428. doi: 10.1054/bjoc.2000.1609

Predicted long-term mortality reduction associated with the second round of breast screening in East Anglia

J McCann 1, S Duffy 2, N Day 3; on behalf of the East Anglian breast screening programme (Director of Quality Assurance: R Warren)
PMCID: PMC2363729  PMID: 11161411

Abstract

Randomized trials have demonstrated that mammographic screening can reduce breast cancer mortality. Our aim was to estimate the reduction in mortality expected from the East Anglian breast screening programme. Breast screening achieves benefit by improving cancer prognosis (reducing tumour size, nodal involvement and possibly grade) through earlier diagnosis. We compared cancer prognosis between women invited for screening and those not yet invited in East Anglia, UK, in order to predict the mortality reduction achievable by screening, independently of any reduction due to changes in treatment and underlying disease. Participants (both invited and not-yet invited) were women eligible for invitation to first and second screens and diagnosed with invasive breast cancer in 1989–96. Death rates were predicted based on the observed distribution of tumour grade, size and node status amongst 950 cancers diagnosed following first invitation, up to and including at second screen (excluding those detected at first screening), and 451 cancers presenting symptomatically in women awaiting first invitation during the staggered introduction of screening, after adjustment for lead time amongst screen detected cases. For all ages, the ratio of predicted breast cancer mortality in the invited compared with the uninvited group was 0.85 (95% CI 0.78, 0.93). It was 0.93 (0.80, 1.08) for women aged 50–54 at diagnosis and 0.81 (0.72, 0.91) for those aged 55–64. We conclude that, by 2004, the second round of screening in East Anglia should reduce mortality by around 7% in women below age 55 at diagnosis, and by around 19% in those aged 55–64. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: breast cancer screening, prognosis, detection mode, mortality

Full Text

The Full Text of this article is available as a PDF (121.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beral V., Hermon C., Reeves G., Peto R. Sudden fall in breast cancer death rates in England and Wales. Lancet. 1995 Jun 24;345(8965):1642–1643. doi: 10.1016/s0140-6736(95)90151-5. [DOI] [PubMed] [Google Scholar]
  2. Blanks R. G., Moss S. M., McGahan C. E., Quinn M. J., Babb P. J. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality. BMJ. 2000 Sep 16;321(7262):665–669. doi: 10.1136/bmj.321.7262.665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Day N., McCann J., Camilleri-Ferrante C., Britton P., Hurst G., Cush S., Duffy S. Monitoring interval cancers in breast screening programmes: the east Anglian experience. Quality Assurance Management Group of the East Anglian Breast Screening Programme. J Med Screen. 1995;2(4):180–185. doi: 10.1177/096914139500200402. [DOI] [PubMed] [Google Scholar]
  4. Duffy S. W., Chen H. H., Tabar L., Fagerberg G., Paci E. Sojourn time, sensitivity and positive predictive value of mammography screening for breast cancer in women aged 40-49. Int J Epidemiol. 1996 Dec;25(6):1139–1145. doi: 10.1093/ije/25.6.1139. [DOI] [PubMed] [Google Scholar]
  5. Gøtzsche P. C., Olsen O. Is screening for breast cancer with mammography justifiable? Lancet. 2000 Jan 8;355(9198):129–134. doi: 10.1016/S0140-6736(99)06065-1. [DOI] [PubMed] [Google Scholar]
  6. McCann J., Stockton D., Day N. Breast cancer in East Anglia: the impact of the breast screening programme on stage at diagnosis. J Med Screen. 1998;5(1):42–48. doi: 10.1136/jms.5.1.42. [DOI] [PubMed] [Google Scholar]
  7. Peto R., Boreham J., Clarke M., Davies C., Beral V. UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet. 2000 May 20;355(9217):1822–1822. doi: 10.1016/S0140-6736(00)02277-7. [DOI] [PubMed] [Google Scholar]
  8. Sjönell G., Ståhle L. Hälsokontroller med mammografi minskar inte dödlighet i bröstcancer. Lakartidningen. 1999 Feb 24;96(8):904-5, 908-13. [PubMed] [Google Scholar]
  9. Stockton D., Davies T., Day N., McCann J. Retrospective study of reasons for improved survival in patients with breast cancer in east Anglia: earlier diagnosis or better treatment. BMJ. 1997 Feb 15;314(7079):472–475. doi: 10.1136/bmj.314.7079.472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Tabar L., Fagerberg G., Chen H. H., Duffy S. W., Smart C. R., Gad A., Smith R. A. Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer. 1995 May 15;75(10):2507–2517. doi: 10.1002/1097-0142(19950515)75:10<2507::aid-cncr2820751017>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  11. Tabàr L., Fagerberg G., Duffy S. W., Day N. E., Gad A., Gröntoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am. 1992 Jan;30(1):187–210. [PubMed] [Google Scholar]
  12. Tabár L., Duffy S. W., Vitak B., Chen H. H., Prevost T. C. The natural history of breast carcinoma: what have we learned from screening? Cancer. 1999 Aug 1;86(3):449–462. [PubMed] [Google Scholar]
  13. Tabár L., Faberberg G., Day N. E., Holmberg L. What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer. 1987 May;55(5):547–551. doi: 10.1038/bjc.1987.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Tabár L., Fagerberg C. J., Gad A., Baldetorp L., Holmberg L. H., Gröntoft O., Ljungquist U., Lundström B., Månson J. C., Eklund G. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet. 1985 Apr 13;1(8433):829–832. doi: 10.1016/s0140-6736(85)92204-4. [DOI] [PubMed] [Google Scholar]
  15. Woodman C. B., Threlfall A. G., Boggis C. R., Prior P. Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region. BMJ. 1995 Jan 28;310(6974):224–226. doi: 10.1136/bmj.310.6974.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Young K. C., Wallis M. G., Blanks R. G., Moss S. M. Influence of number of views and mammographic film density on the detection of invasive cancers: results from the NHS Breast Screening Programme. Br J Radiol. 1997 May;70(833):482–488. doi: 10.1259/bjr.70.833.9227229. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES